The evaluation of sleep quality, anxiety disorder and depression in older adults with Parkinson disease
Makaleler > Tam Makale · 2021
Yazarlar: Gülay İlkhan Daşdemir, Hakan Çelikhisar, Aslı KILAVUZ
Journal of Health Sciences and Medicine, Diğer Kurumların Hakemli Dergileri, Uluslararası, Scopus, 2021, cilt 4, ss 147-153
DOI: 10.32322/jhsm.848699
Özet
<p><br></p><p class="p2" style="margin-top: 1px; margin-bottom: 1px; text-align: justify; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 10px; line-height: normal; font-family: Times;"><span class="s1" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 12px; line-height: normal;"> </span><b>Aim: </b>The aim of this study was to examine the prevalence ratios of sleep disorder, anxiety and depression in older adults with Parkinson disease in addition to the relationship between these complaints and the stage and duration of the disease.<span class="Apple-converted-space"> </span></p><p class="p2" style="margin-top: 1px; margin-bottom: 1px; text-align: justify; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 10px; line-height: normal; font-family: Times;"><b>Material and Method: </b>Epworth sleepiness scale, Pittsburgh sleep quality index, Insomnia severity index, Beck depression inventory, Hamilton anxiety scale were applied on a total of 585 older adults followed up with Parkinson disease diagnosis. The acquired results were interpreted by comparing with the data of the control group comprised of 585 healthy individuals.<span class="Apple-converted-space"> </span></p><p class="p2" style="margin-top: 1px; margin-bottom: 1px; text-align: justify; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 10px; line-height: normal; font-family: Times;"><b>Results: </b>A total of 585 older adult with Parkinson disease and 585 healthy controls were included in the study. Each group was comprised of 255 female (43.59%) and 330 male (56.41%) participants. Mean age of the Parkinson group was 68.14±7.01 years, whereas mean age of the control group was 65.08±6.43 years. Mean Hoehn Yahr scale was determined in the Parkinson group as 1.8; while mean UPDRS was 29.8. Daytime functions and subjective sleep quality were worse at a statistically significant level in the patient group according to Pittsburgh sleep quality index (p=0.014, p=0.019, respectively). The most significant difference was observed in ESS when the scale scores of the patient and control groups were compared (p<0.001). A positive and statistically significant correlation was determined between the Beck depression inventory score and unified Parkinson’s disease rating scale and Hoehn Yahr scale (p=0.023, p=0.034, respectively). While depression ratio increases with increasing stages of the disease, anxiety ratios increased with increasing disease duration. A positive and statistically significant correlation was determined between the weight of the disease and the score obtained from the somatic section of HAM-A (p=0.022).<span class="Apple-converted-space"> </span></p><p class="p2" style="margin-top: 1px; margin-bottom: 1px; text-align: justify; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 10px; line-height: normal; font-family: Times;"><b>Conclusion: </b>The presence of depression and anxiety should be questioned especially in older adult with Parkinson disease who are clinically more severe and who have been undergoing treatment for a longer period of time; patients with treatment related complications should be evaluated with regard to sleep disorders. It should be kept in mind that the Parkinson disease is not related only with motor symptoms but that an effective treatment of the non-motor symptoms will also improve the quality of life of the patients.<span class="Apple-converted-space"> </span></p>